posaconazol
J - Antiinfectives For Systemic Use -> J02 - Antimycotics For Systemic Use -> J02A - Antimycotics For Systemic Use -> J02AC - Triazole Derivatives -> J02AC04 - Posaconazole
Administration category:
Free
Medicine group:
antifungal
Brand name:
Noxafil
Standard dosages
| Weight | ROA | Load | Dosage | |
|---|---|---|---|---|
|
ROA: po |
Load: 300mg |
Dosage: 300mg 1 dd |
||
|
ROA: iv |
Load: 300mg |
Dosage: 300mg 1 dd |
||
|
Comments:
iv: dag 1 oplaad 300 mg 2 dd, dag 2 e.v. 300 mg 1 dd. po tabletten: dag 1 oplaad 300 mg 2 dd, dag 2 e.v. 300 mg 1 dd. Tabletten hebben de voorkeur boven suspensie. Spiegelcontrole (TDM) wenselijk. |
||||
Kidney function
Renal elimination:
0%
Dosage:
independent on kidney function
Interactions
| Interaction with (ATC): | Expected effect: |
|---|---|
|
Interaction with (ATC): L04AD01 - Ciclosporin |
Expected effect: spiegel ciclosporine wordt hoger |
|
Interaction with (ATC): L04AD02 - Tacrolimus |
Expected effect: spiegel tacrolimus wordt hoger |
Pregnancy
Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Zwangerschap#TOC_Middelen_bij6
- http://www.lareb.nl//Teratologie/Naslagwerk-GZB/GZB---Borstvoeding#TOC_Middelen_bij16
For individual advice, consult an expert on site.
Metadata
Swab vid: M-2146.4
Updated: 06/16/2019 - 20:05
Status: Published